The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Can Controversial Nanotechnology Promise Drug Delivery?
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTCan Controversial Nanotechnology Promise Drug Delivery?Venkat Ratnam Devadasu, Vivekanand Bhardwaj, and M. N. V. Ravi Kumar*View Author Information Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, United Kingdom*E-mail: [email protected]Cite this: Chem. Rev. 2013, 113, 3, 1686–1735Publication Date (Web):December 31, 2012Publication History Received7 February 2012Published online31 December 2012Published inissue 13 March 2013https://pubs.acs.org/doi/10.1021/cr300047qhttps://doi.org/10.1021/cr300047qreview-articleACS PublicationsCopyright © 2012 American Chemical SocietyRequest reuse permissionsArticle Views10148Altmetric-Citations172LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Drug delivery,Molecules,Nanoparticles,Pharmaceuticals,Polymers Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Cited by
Wu, W., Wu, Z., Yu, T., Jiang, C., & Kim, W.-S. (2015) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/16/2/023501 · Cited by 1,574
Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 841
Qiu, M., Wang, D., Liang, W., Liu, L., Zhang, Y., Chen, X., Sang, D. K., Xing, C., Li, Z., Dong, B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714421115 · Cited by 812
Duan, Q., Cao, Y., Li, Y., Hu, X., Xiao, T., Lin, C., Pan, Y., & Wang, L. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405014r · Cited by 644
García, K. P., Zarschler, K., Barbaro, L., Barreto, J. A., O'Malley, W., Spiccia, L., Stephan, H., & Graham, B. (2014) · Small · doi:10.1002/smll.201303540 · Cited by 519
Polymeric Nanostructures for Imaging and Therapy
Elsabahy, M., Heo, G. S., Lim, S.-M., Sun, G., & Wooley, K. L. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00135 · Cited by 508
Ariga, K., Yamauchi, Y., Mori, T., & Hill, J. P. (2013) · Advanced Materials · doi:10.1002/adma.201302283 · Cited by 493
Designing Hydrogels for On-Demand Therapy
Oliva, N., Conde, J., Wang, K., & Artzi, N. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00536 · Cited by 371
Remote Light‐Responsive Nanocarriers for Controlled Drug Delivery: Advances and Perspectives
Zhao, W., Zhao, Y., Wang, Q., Liu, T., Sun, J., & Zhang, R. (2019) · Small · doi:10.1002/smll.201903060 · Cited by 329
Wang, H., Li, P., Yu, D., Zhang, Y., Wang, Z., Liu, C., Qiu, H., Liu, Z., Ren, J., & Qu, X. (2018) · Nano Letters · doi:10.1021/acs.nanolett.7b05095 · Cited by 279
Metadata
- Authors
- Devadasu, V. R., Bhardwaj, V., & Kumar, M. N. V. R.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-12-31
- Volume
- 113
- Issue
- 3
- Pages
- 1686-1735
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2313847381
- Cited by
- 210
- References
- 39
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.